{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:47:33Z","timestamp":1789055253728,"version":"build-2803163510"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Carbapenem-resistant <jats:italic>Acinetobacter baumannii<\/jats:italic> (CR<jats:italic>Ab<\/jats:italic>) causes severe infections and poses significant treatment challenges. Sulbactam-durlobactam (SUL-DUR) is a novel antibiotic, but its use in children and infants has not been reported. We reported the first case of an infant with acute leukemia successfully treated with SUL-DUR for CR<jats:italic>Ab<\/jats:italic> sepsis with cutaneous involvement.<\/jats:p>","DOI":"10.3389\/fphar.2025.1633982","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T05:33:26Z","timestamp":1756964006000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Sulbactam-durlobactam combination therapy for carbapenem-resistant Acinetobacter baumannii sepsis with cutaneous involvement in an infant with acute monocytic leukemia: A case report"],"prefix":"10.3389","volume":"16","author":[{"given":"Chunxi","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1001\/jamadermatol.2013.8855","article-title":"Acinetobacter baumannii emerging as a multidrug-resistant skin and soft-tissue pathogen: parallels to methicillin-resistant Staphylococcus aureus","volume":"150","author":"Adler","year":"2014","journal-title":"JAMA Dermatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.ijscr.2014.04.019","article-title":"Fatal skin and soft tissue infection of multidrug resistant acinetobacter baumannii: a case report","volume":"5","author":"Ali","year":"2014","journal-title":"Int. J. Surg. Case Rep."},{"key":"B3","first-page":"181","article-title":"Colistin, meropenem and rifampin in a combination therapy for multi-drug-resistant Acinetobacter baumannii multifocal infection. A case report","volume":"73","author":"Biancofiore","year":"2007","journal-title":"Minerva Anestesiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1128\/jcm.01250-08","article-title":"Two cases of necrotizing fasciitis due to Acinetobacter baumannii","volume":"47","author":"Charnot-Katsikas","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1097\/TP.0b013e318265083b","article-title":"Multidrug-resistant Acinetobacter baumannii causing necrotizing fasciitis in a pancreas-kidney transplant recipient: a case report","volume":"94","author":"Clemente","year":"2012","journal-title":"Transplantation"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e752","DOI":"10.1016\/s2214-109x(16)30148-6","article-title":"Characterisation and antimicrobial resistance of sepsis pathogens in neonates born in tertiary care centres in Delhi, India: a cohort study","volume":"4","author":"Collaboration","year":"2016","journal-title":"Lancet Glob. Health"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1093\/cid\/ciad100","article-title":"Mortality attributable to bloodstream infections caused by different carbapenem-resistant gram-negative bacilli: results from a nationwide study in Italy (ALARICO network)","volume":"76","author":"Falcone","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.jgar.2022.05.011","article-title":"In vitro activity of sulbactam-durlobactam against carbapenem-resistant Acinetobacter baumannii and mechanisms of resistance","volume":"30","author":"Findlay","year":"2022","journal-title":"J. Glob. Antimicrob. Resist"},{"key":"B9","volume-title":"FDA approves new treatment for pneumonia caused by certain difficult-to-treat bacteria","author":"Food","year":"2023"},{"key":"B10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1089\/sur.2009.022","article-title":"Acinetobacter baumannii-associated skin and soft tissue infections: recognizing a broadening spectrum of disease","volume":"11","author":"Guerrero","year":"2010","journal-title":"Surg. Infect. (Larchmt)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e1234","DOI":"10.1016\/j.ijid.2013.05.002","article-title":"Successful treatment of skin and soft tissue infection due to carbapenem-resistant Acinetobacter baumannii by ampicillin-sulbactam and meropenem combination therapy","volume":"17","author":"Hiraki","year":"2013","journal-title":"Int. J. Infect. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.2147\/idr.S305819","article-title":"Outcomes of adjunctive therapy with intravenous cefoperazone-sulbactam for ventilator-associated pneumonia due to carbapenem-resistant Acinetobacter baumannii","volume":"14","author":"Kanchanasuwan","year":"2021","journal-title":"Infect. Drug Resist"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e0078122","DOI":"10.1128\/aac.00781-22","article-title":"In vitro activity of sulbactam-durlobactam against global isolates of acinetobacter baumannii-calcoaceticus complex collected from 2016 to 2021","volume":"66","author":"Karlowsky","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/s1473-3099(23)00184-6","article-title":"Efficacy and safety of sulbactam-durlobactam versus colistin for the treatment of patients with serious infections caused by acinetobacter baumannii-calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK)","volume":"23","author":"Kaye","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1080\/09273948.2022.2103715","article-title":"Acinetobacter baumannii-calcoaceticus complex-associated orbital cellulitis: a case report and literature review","volume":"31","author":"Lai","year":"2023","journal-title":"Ocul. Immunol. Inflamm."},{"key":"B16","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jmii.2014.04.005","article-title":"Clonal dissemination of extensively drug-resistant Acinetobacter baumannii producing an OXA-23 \u03b2-lactamase at a teaching hospital in shanghai, China","volume":"48","author":"Li","year":"2015","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B17","doi-asserted-by":"publisher","first-page":"piaf004","DOI":"10.1093\/jpids\/piaf004","article-title":"Suggested dosing of select beta-lactam agents for the treatment of antimicrobial-resistant gram-negative infections in children","volume":"14","author":"Lockowitz","year":"2025","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e01751-18","DOI":"10.1128\/jcm.01751-18","article-title":"The brief case: a fatal case of necrotizing fasciitis due to multidrug-resistant Acinetobacter baumannii","volume":"57","author":"Matthews","year":"2019","journal-title":"J. Clin. Microbiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jiac.2013.12.011","article-title":"Community-acquired necrotizing fasciitis caused by acinetobacter calcoaceticus: a case report and literature review","volume":"20","author":"Nonaka","year":"2014","journal-title":"J. Infect. Chemother."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e118","DOI":"10.1016\/j.oooo.2019.02.012","article-title":"Acinetobacter baumannii orofacial cellulitis: report of 2 cases","volume":"127","author":"Pereira","year":"2019","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"344","DOI":"10.11604\/pamj.2020.36.344.24614","article-title":"Monomicrobian necrotizing fasciitis of the leg due to multidrug-resistant Acinetobacter baumannii in a healthy adult: about a case","volume":"36","author":"Ramampisendrahova","year":"2020","journal-title":"Pan Afr. Med. J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/1471-2334-13-252","article-title":"Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based study","volume":"13","author":"Ray","year":"2013","journal-title":"BMC Infect. Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"S179","DOI":"10.1093\/cid\/ciad094","article-title":"Navigating available treatment options for carbapenem-resistant acinetobacter baumannii-calcoaceticus complex infections","volume":"76","author":"Shields","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"705279","DOI":"10.1155\/2014\/705279","article-title":"A fatal case of multidrug resistant acinetobacter necrotizing fasciitis: the changing scary face of nosocomial infection","volume":"2014","author":"Sinha","year":"2014","journal-title":"Case Rep. Infect. Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1177\/000313481007600636","article-title":"Fatal case of multi-drug resistant Acinetobacter baumannii necrotizing fasciitis","volume":"76","author":"Sullivan","year":"2010","journal-title":"Am. Surg."},{"key":"B26","doi-asserted-by":"publisher","first-page":"ciae403","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious diseases society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections","author":"Tamma","year":"2024","journal-title":"Clin. Infect. Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e0162724","DOI":"10.1128\/aac.01627-24","article-title":"A microbiological and structural analysis of the interplay between sulbactam\/durlobactam and imipenem against penicillin-binding proteins (PBPs) of acinetobacter spp","volume":"69","author":"Veeraraghavan","year":"2025","journal-title":"Antimicrob. Agents Chemother."},{"key":"B28","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3390\/microorganisms8060935","article-title":"Antibiotic resistance profiles, molecular mechanisms and innovative treatment strategies of Acinetobacter baumannii","volume":"8","author":"Vrancianu","year":"2020","journal-title":"Microorganisms"},{"key":"B29","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/cid\/ciad556","article-title":"Clinical outcomes and bacterial characteristics of carbapenem-resistant Acinetobacter baumannii among patients from different global regions","volume":"78","author":"Wang","year":"2024","journal-title":"Clin. Infect. Dis."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1633982\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T05:33:27Z","timestamp":1756964007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1633982\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,4]]},"references-count":29,"alternative-id":["10.3389\/fphar.2025.1633982"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1633982","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,4]]},"article-number":"1633982"}}